SKYE
SKYE
NASDAQ · Biotechnology

Skye Bioscience Inc

$0.82
+0.02 (+2.48%)
As of Feb 8, 2:23 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 3.64M 3.84M 3.77M
Net Income 720.4K 800.4K 930.4K
EPS
Profit Margin 19.8% 20.8% 24.7%
Rev Growth +15.7% +20.7% +9.8%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 5.10M 5.57M 5.69M
Total Equity 15.19M 15.89M 15.26M
D/E Ratio 0.34 0.35 0.37
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 1.38M 1.54M 1.32M
Free Cash Flow 559.4K 545.0K 561.2K